Crispr Therapeutics shares tumble after significant earnings miss
Investing.com -- Arbor Realty Trust , Inc. (NYSE:ABR) shares jumped 3.9% after the real estate investment trust reported second-quarter earnings and revenue that exceeded analyst expectations, despite a significant year-over-year decline in distributable earnings.
The company posted distributable earnings of $0.25 per diluted share for the quarter ended June 30, 2025, surpassing the analyst estimate of $0.23. Revenue came in at $130.41 million, above the consensus estimate of $129.66 million. However, distributable earnings were down substantially from $0.45 per share in the same quarter last year. The company declared a cash dividend of $0.30 per share, maintaining its previous payout level.
The company’s structured loan portfolio grew to approximately $11.61 billion, with originations of $716.5 million and runoff of $519.7 million during the quarter. The agency business generated $857.1 million in loan originations, a significant increase from $605.9 million in the previous quarter. The fee-based servicing portfolio reached $33.76 billion at quarter-end.
Arbor also reported foreclosing on six loans totaling $188.2 million and selling four real estate owned properties totaling $114.5 million. The company recorded a $16.1 million net provision for loan losses associated with CECL during the quarter.
In July 2025, Arbor issued $500 million of 7.875% senior unsecured notes due 2030, which will be used to repay $287.5 million of convertible senior notes and add approximately $200 million of liquidity.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.